Dr. Nancy Lin: Are CNS Mets Becoming More Treatable? What’s New with STOP-HER2?
Novel Treatments, Medical Community, Challenges and Barriers, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Clinical Research, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Clinical Research, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options Our MBClife

Dr. Nancy Lin: Are CNS Mets Becoming More Treatable? What’s New with STOP-HER2?

Brain metastases are unfortunately an all too common and devastating complication of breast cancer. The blood-brain barrier has long been a key obstacle to developing effective systemic therapies; however, newer agents are showing signs of overcoming this challenge. Dr. Nancy Lin explains.

Read More
Road to a Cure - Dr. Heather Parsons & Dr. Nancy Lin
Novel Treatments, Medical Community, Challenges and Barriers, MBC Research Funding, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Clinical Research Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, MBC Research Funding, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat, Obstacles to Better Outcomes, Patient Reported Outcomes and Out of the Box Treatment Options, Clinical Research Our MBClife

Road to a Cure - Dr. Heather Parsons & Dr. Nancy Lin

The Road to a Cure series heads to Boston to have Senior Producer and Co-host, Victoria Goldberg and co-host Dr. Paula Jayne speak with Dr. Nancy Lin and Dr. Heather Parsons about the possibilities and the current barriers to considering a cure for HER2+ MBC. Dr. Parsons and Dr. Lin are medical oncologists and professors at Harvard Medical School. Dr. Lin is also the Director of the Metastatic Breast Cancer Program and the Associate Chief of the Division of Breast Oncology at Dana Farber Cancer Institute. While an amazing gift, long-term survival among some HER2+ patients can also sometimes bring special challenges. Given the higher prevalence of brain metastases among HER2+ patients, Drs. Lin and Parsons also discuss current research on brain mets, along with areas of promising overall MBC research for each subtype.

Read More
Road to a Cure - Dr. Sara Hurvitz
Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife Novel Treatments, Medical Community, Challenges and Barriers, Clinical Research, Obstacles to Better Outcomes, Diagnosis and Treatment, Entities of Cancer, MBC Imaging and Profiling, Difficult to Treat Our MBClife

Road to a Cure - Dr. Sara Hurvitz

The Road to a Cure series gets on the redeye to LA to have Senior Producer and Co-host, Victoria Goldberg and co-host Kate Pfitzer speak with Dr. Sara Hurvitz. She talks about her perspective on where we are as we work for a cure, the HER2+ studies she is excited about, and other research that is intriguing as it relates to all subtypes

Read More
Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer
Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife Novel Treatments, Medical Community, Clinical Research, Entities of Cancer, Updates from Conferences, Difficult to Treat, Obstacles to Better Outcomes Our MBClife

Report Back from ASCO: What’s the Latest in Metastatic Breast Cancer

Are you living with ER+/HER2- or TNBC MBC and tired of hearing about new HER2 therapies and wondering when it will be your turn? Just after the meeting SHARE welcomed Dr. Timothy Pluard from University of Missouri-KC School of Medicine to a webinar highlighting promising data from trials and labs across the globe presented at the this year’s meeting,

Read More
Report back from SABCS
Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife Medical Community, Clinical Research, Lifestyle Research, Diagnosis and Treatment, Updates from Conferences, Entities of Cancer, Novel Treatments, Obstacles to Better Outcomes, Difficult to Treat, MBC Imaging and Profiling Our MBClife

Report back from SABCS

Welcome to this bonus episode of Our MBC Life. It feels like a lifetime ago, but just a few weeks ago the world's largest breast cancer conference, the San Antonio Breast Cancer Symposium, was held. Just after the symposium SHARE welcomed Dr. Neil Iyengar from Memorial Sloan Kettering to a webinar where he shared information from SABCS highlighting both early-stage and metastatic research.

Read More
Nancy U. Lin, MD
Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife Medical Community, Novel Treatments, Essential Knowledge, Diagnosis and Treatment, Challenges and Barriers, Obstacles to Better Outcomes, Clinical Research, Difficult to Treat, MBC Imaging and Profiling, Entities of Cancer Our MBClife

Nancy U. Lin, MD

A conversation with Dr. Nancy Lin, Director of the Metastatic Breast Cancer Program at Dana-Farber Cancer Institute.

Read More